www.fdanews.com/articles/195623-vivalnk-wearable-ecg-sensor-platform-cleared
VivaLNK Wearable ECG Sensor Platform Cleared
January 24, 2020
VivaLNK received FDA clearance for its Continuous ECG Platform that includes reusable wearable ECG sensors and a software development kit that gives developers and providers direct control over data.
Application developers can use the VivaLNK platform to send sensor data directly to the application. The sensor does not collect personally identifiable information.
The software development kit also integrates with the previously FDA cleared and CE Marked VivaLNK temperature sensor, so multiple vitals to be remotely monitored from a single platform.